Prevalence of Seasonal Influenza Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Balearic Islands (Spain) and Its Effect on COPD Exacerbations: A Population-Based Retrospective Cohort Study

Autor: Miguel Román-Rodríguez, Job F M van Boven, Laura Ruiz Azcona, Montserrat Llort Bove, Miguel Santibáñez Margüello
Přispěvatelé: Universidad de Cantabria, Groningen Research Institute for Asthma and COPD (GRIAC), Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
Rok vydání: 2020
Předmět:
Male
Health
Toxicology and Mutagenesis

humanos
primary prevention
lcsh:Medicine
Logistic regression
Cohort Studies
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
Prevalence
030212 general & internal medicine
estudios de cohortes
COPD
education.field_of_study
prevalencia
Vaccination
influenza vaccination
COPD exacerbations
Disease Progression
Female
Seasons
Cohort study
medicine.medical_specialty
Population
Article
chronic obstructive pulmonary disease
vacunación
03 medical and health sciences
progresión de la enfermedad
Internal medicine
Statistical significance
Influenza
Human

medicine
Humans
education
Retrospective Studies
Asthma
business.industry
estudios retrospectivos
lcsh:R
Public Health
Environmental and Occupational Health

copd
Retrospective cohort study
medicine.disease
estaciones (meteorología)
respiratory tract diseases
030228 respiratory system
Spain
business
Zdroj: International Journal of Environmental Research and Public Health, Vol 17, Iss 4027, p 4027 (2020)
Int. J. Environ. Res. Public Health 2020, 17(11), 4027
UCrea Repositorio Abierto de la Universidad de Cantabria
instname
International Journal of Environmental Research and Public Health, 17(11):4027, 1-12. MDPI AG
International Journal of Environmental Research and Public Health
Volume 17
Issue 11
ISSN: 1660-4601
1661-7827
DOI: 10.3390/ijerph17114027
Popis: To determine the prevalence of influenza vaccination in chronic obstructive pulmonary disease (COPD) patients and its effect on COPD exacerbations, we conducted a retrospective population-based cohort study analyzing real-life data. We included all registered COPD patients &ge
40 years old using respiratory medication during the study period (2012&ndash
2013). Influenza vaccination during the 2012/2013 campaign was the parameter studied. Moderate and severe exacerbations during 2013 were the dependent outcome variables. Logistic regression adjusting for age, gender, concomitant asthma diagnosis, COPD severity, smoking status, number of moderate and severe exacerbations the previous year, and comorbidities was performed, and 59.6% of the patients received seasonal influenza vaccination. The percentage of patients with exacerbations was higher among those vaccinated. Influenza vaccination had a statistically significantly negative (non-protective) crude effect favoring the risk of severe exacerbations: OR: 1.20 (95% CI
1.05&ndash
1.37). This association diminished and lost statistical significance after adjustment: aOR: 0.93 (95% CI
0.74&ndash
1.18). The protective effect in the analysis restricted to the epidemic period was not significant: aOR: 0.82 (95% CI
0.58&ndash
1.16). We concluded that prevalence of influenza vaccination was suboptimal. In contrast with most of the available evidence, our results did not support a protective effect of influenza vaccination on the risk of admission for COPD exacerbation.
Databáze: OpenAIRE